Dr. Anthony Fauci (center), Dr. Robert Redfield (right) and Adm. Brett Giroir testify during a House Subcommittee hearing on the coronavirus crisis on Friday, July 31.

Dr. Anthony Fauci (center), Dr. Robert Redfield (right) and Adm. Brett Giroir testify during a House Subcommittee hearing on the coronavirus crisis on Friday, July 31. Kevin Dietsch/AP

Federal Officials Point to Underfunding, Lockdown Avoidance for Coronavirus Failings

Anthony Fauci and other agency leaders push back on allegations the federal government hasn’t done enough to confront the pandemic.

Federal public health officials on Friday defended the actions their agencies have taken to prevent the spread of the novel coronavirus, pushing back on allegations the Trump administration has dragged its feet in confronting the pandemic. 

Democrats on the House Select Subcommittee on the Coronavirus Crisis repeatedly needled officials for the Trump administration's failure to develop a national, comprehensive plan for responding to the outbreak, saying it has led to thousands of unnecessary deaths. While in several instances federal agency leaders testifying at the hearing rebuked false comments repeated by President Trump, they stressed that they and their expert employees had been given the freedom to do their jobs. 

One notable exception came as Centers for Disease Control and Prevention Director Robert Redfield said he had no advanced knowledge of the decision to require hospitals to report their coronavirus data to a private contractor through the Health and Human Services Department, instead of CDC directly. 

The agency “wasn’t involved in the decision,” Redfield said. “I was told once the [HHS] Secretary [Alex Azar]’s office made the decision that that was the decision.” 

HHS has said the change would lead to better data management and increased reporting, though critics have said CDC is better positioned for transparent and nonpartisan recordkeeping. 

Redfield said his agency does have a “comprehensive response” to the pandemic, highlighting CDC’s work assisting counterparts in more than 60 countries, obligating $12 billion to help states ramp up contact tracing, coordinating AmeriCorps and 300 of its own staff to assist state and local governments and other steps. Where there have been shortfalls, Redfield pointed to a long-running trend in failure to properly fund public health agencies at the federal level. 

“The core capabilities have not been invested in over the last five decades,” Refield said, later adding, “Clearly we were handicapped when this outbreak started.” 

Adm. Brett Giroir, assistant secretary of heath at HHS, also praised the work of his department and, in particular, the U.S. Public Health Service that he leads. While the Trump administration has faced significant criticism for allowing a patchwork of responses in each state across the country, Giroir said the federal coordination has been significant. 

“This has always been a collaborative relationship,” he said. “We do not defer everything to the state. If we did, I would not be spending 24/7 with a team of 50 people since March 12.” 

Rep. Jim Clyburn, D-S.C., however, who chairs the panel that held Friday’s hearing, said there is “still no strategy.” 

“Regrettably, nearly six months after this virus clinches its first American life, the federal government has still not developed and implemented a national strategy to protect the American people,” Clyburn said. Absent “drastic changes,” he added, the country is likely to double the current 150,000 coronavirus death toll in the coming months. 

Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, said his agency has overseen a record-setting pace toward developing therapeutics and a vaccine. NIAID has removed red tape at each step, he said, allowing drug companies to move quickly into late phases of trials for vaccine candidates. He emphasized the approach has not compromised safety, nor did it equate to cutting corners.  

As part of the White House’s Operation Warp Speed, the administration's public-private partnership effort to develop a vaccine, HHS announced on Friday it had signed a $2.1 billion contract with Sanofi and GlaxoSmithKline to develop trials and possible distribution of 100 million doses of a potential vaccine. The Trump administration has already signed contracts with other companies, with public health officials stressing the government is looking to take on the financial risk involved with vaccine development. Fauci said NIAID and the Biomedical Advanced Research and Development Authority have worked directly with companies like Moderna on those efforts and reiterated he was “cautiously optimistic” a candidate could prove effective by the end of the year. 

Fauci and his colleagues stressed the importance of Americans following personal hygiene recommendations and universal mask wearing. Cases in Europe have plummeted and remained low because lockdowns there led to 95% participation, whereas in the United States that rate was around 50%, he said. 

Republicans on the panel focused their questions on the negative impacts of lockdowns, including business closures, upticks in substance abuse and underreporting of child abuse. Among the panelists, CDC’s Redfield in particular emphasized the importance of schools opening this fall. Giroir highlighted his office’s work in ensuring schools can reopen safely, including surveillance testing on college campuses and, potentially, K-12 institutions. 

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.